vs

Side-by-side financial comparison of IDACORP INC (IDA) and NEOGEN CORP (NEOG). Click either name above to swap in a different company.

IDACORP INC is the larger business by last-quarter revenue ($360.1M vs $224.7M, roughly 1.6× NEOGEN CORP). IDACORP INC runs the higher net margin — 12.1% vs -7.1%, a 19.2% gap on every dollar of revenue. On growth, NEOGEN CORP posted the faster year-over-year revenue change (-2.8% vs -4.2%). NEOGEN CORP produced more free cash flow last quarter ($7.8M vs $-216.2M). Over the past eight quarters, NEOGEN CORP's revenue compounded faster (-0.9% CAGR vs -7.2%).

IDACORP, Inc is an electricity holding company, incorporated in Idaho with headquarters in Boise. It comprises Idaho Power Company, IDACORP Financial and Ida-West Energy. It was formed on October 1, 1998.

Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abuse...

IDA vs NEOG — Head-to-Head

Bigger by revenue
IDA
IDA
1.6× larger
IDA
$360.1M
$224.7M
NEOG
Growing faster (revenue YoY)
NEOG
NEOG
+1.4% gap
NEOG
-2.8%
-4.2%
IDA
Higher net margin
IDA
IDA
19.2% more per $
IDA
12.1%
-7.1%
NEOG
More free cash flow
NEOG
NEOG
$224.0M more FCF
NEOG
$7.8M
$-216.2M
IDA
Faster 2-yr revenue CAGR
NEOG
NEOG
Annualised
NEOG
-0.9%
-7.2%
IDA

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
IDA
IDA
NEOG
NEOG
Revenue
$360.1M
$224.7M
Net Profit
$43.6M
$-15.9M
Gross Margin
47.5%
Operating Margin
14.9%
-2.4%
Net Margin
12.1%
-7.1%
Revenue YoY
-4.2%
-2.8%
Net Profit YoY
15.1%
96.5%
EPS (diluted)
$0.78
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDA
IDA
NEOG
NEOG
Q4 25
$360.1M
$224.7M
Q3 25
$526.4M
$209.2M
Q2 25
$449.3M
$225.4M
Q1 25
$411.1M
$221.0M
Q4 24
$375.9M
$231.3M
Q3 24
$532.5M
$217.0M
Q2 24
$442.6M
$236.8M
Q1 24
$417.9M
$228.8M
Net Profit
IDA
IDA
NEOG
NEOG
Q4 25
$43.6M
$-15.9M
Q3 25
$124.4M
$36.3M
Q2 25
$95.8M
$-612.3M
Q1 25
$59.6M
$-10.9M
Q4 24
$37.9M
$-456.3M
Q3 24
$113.6M
$-12.6M
Q2 24
$89.5M
$-5.4M
Q1 24
$48.2M
$-2.0M
Gross Margin
IDA
IDA
NEOG
NEOG
Q4 25
47.5%
Q3 25
45.4%
Q2 25
41.2%
Q1 25
49.9%
Q4 24
49.0%
Q3 24
48.4%
Q2 24
47.9%
Q1 24
51.1%
Operating Margin
IDA
IDA
NEOG
NEOG
Q4 25
14.9%
-2.4%
Q3 25
27.5%
-7.7%
Q2 25
22.4%
-271.1%
Q1 25
13.4%
2.4%
Q4 24
11.0%
-197.8%
Q3 24
25.1%
1.0%
Q2 24
23.3%
5.5%
Q1 24
11.9%
5.3%
Net Margin
IDA
IDA
NEOG
NEOG
Q4 25
12.1%
-7.1%
Q3 25
23.6%
17.4%
Q2 25
21.3%
-271.6%
Q1 25
14.5%
-4.9%
Q4 24
10.1%
-197.3%
Q3 24
21.3%
-5.8%
Q2 24
20.2%
-2.3%
Q1 24
11.5%
-0.9%
EPS (diluted)
IDA
IDA
NEOG
NEOG
Q4 25
$0.78
$-0.07
Q3 25
$2.26
$0.17
Q2 25
$1.76
$-2.82
Q1 25
$1.10
$-0.05
Q4 24
$0.72
$-2.10
Q3 24
$2.12
$-0.06
Q2 24
$1.71
$-0.02
Q1 24
$0.95
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDA
IDA
NEOG
NEOG
Cash + ST InvestmentsLiquidity on hand
$215.7M
$145.3M
Total DebtLower is stronger
$3.3B
Stockholders' EquityBook value
$3.6B
$2.1B
Total Assets
$10.2B
$3.4B
Debt / EquityLower = less leverage
0.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDA
IDA
NEOG
NEOG
Q4 25
$215.7M
$145.3M
Q3 25
$333.2M
$138.9M
Q2 25
$474.5M
$129.0M
Q1 25
$634.5M
$127.7M
Q4 24
$368.9M
$140.2M
Q3 24
$427.9M
$120.5M
Q2 24
$169.6M
$170.9M
Q1 24
$157.6M
$168.4M
Total Debt
IDA
IDA
NEOG
NEOG
Q4 25
$3.3B
Q3 25
Q2 25
Q1 25
Q4 24
$3.1B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IDA
IDA
NEOG
NEOG
Q4 25
$3.6B
$2.1B
Q3 25
$3.5B
$2.1B
Q2 25
$3.4B
$2.1B
Q1 25
$3.3B
$2.7B
Q4 24
$3.3B
$2.7B
Q3 24
$3.3B
$3.1B
Q2 24
$3.2B
$3.1B
Q1 24
$2.9B
$3.1B
Total Assets
IDA
IDA
NEOG
NEOG
Q4 25
$10.2B
$3.4B
Q3 25
$10.1B
$3.4B
Q2 25
$9.9B
$3.4B
Q1 25
$9.6B
$4.0B
Q4 24
$9.2B
$4.1B
Q3 24
$9.1B
$4.5B
Q2 24
$8.7B
$4.5B
Q1 24
$8.3B
$4.6B
Debt / Equity
IDA
IDA
NEOG
NEOG
Q4 25
0.93×
Q3 25
Q2 25
Q1 25
Q4 24
0.92×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDA
IDA
NEOG
NEOG
Operating Cash FlowLast quarter
$137.8M
$19.4M
Free Cash FlowOCF − Capex
$-216.2M
$7.8M
FCF MarginFCF / Revenue
-60.0%
3.5%
Capex IntensityCapex / Revenue
98.3%
5.2%
Cash ConversionOCF / Net Profit
3.16×
TTM Free Cash FlowTrailing 4 quarters
$-577.5M
$-18.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDA
IDA
NEOG
NEOG
Q4 25
$137.8M
$19.4M
Q3 25
$162.8M
$10.9M
Q2 25
$176.9M
$16.4M
Q1 25
$124.3M
$19.5M
Q4 24
$136.4M
$40.3M
Q3 24
$201.9M
$-17.9M
Q2 24
$146.4M
$26.7M
Q1 24
$109.7M
$-30.2M
Free Cash Flow
IDA
IDA
NEOG
NEOG
Q4 25
$-216.2M
$7.8M
Q3 25
$-127.9M
$-13.1M
Q2 25
$-156.4M
$349.0K
Q1 25
$-77.0M
$-13.4M
Q4 24
$-48.9M
$23.1M
Q3 24
$-16.1M
$-56.3M
Q2 24
$-199.6M
$2.5M
Q1 24
$-150.3M
$-62.3M
FCF Margin
IDA
IDA
NEOG
NEOG
Q4 25
-60.0%
3.5%
Q3 25
-24.3%
-6.3%
Q2 25
-34.8%
0.2%
Q1 25
-18.7%
-6.1%
Q4 24
-13.0%
10.0%
Q3 24
-3.0%
-26.0%
Q2 24
-45.1%
1.1%
Q1 24
-36.0%
-27.2%
Capex Intensity
IDA
IDA
NEOG
NEOG
Q4 25
98.3%
5.2%
Q3 25
55.2%
11.5%
Q2 25
74.2%
7.1%
Q1 25
49.0%
14.9%
Q4 24
49.3%
7.4%
Q3 24
41.0%
17.7%
Q2 24
78.2%
10.2%
Q1 24
62.2%
14.0%
Cash Conversion
IDA
IDA
NEOG
NEOG
Q4 25
3.16×
Q3 25
1.31×
0.30×
Q2 25
1.85×
Q1 25
2.08×
Q4 24
3.60×
Q3 24
1.78×
Q2 24
1.63×
Q1 24
2.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IDA
IDA

Retailrevenues$323.0M90%
Transmissionserviceswheeling$18.6M5%
Energyefficiencyprogramrevenues$11.7M3%
Wholesaleenergysales$10.5M3%
Otherrevenues$9.5M3%

NEOG
NEOG

Other$109.2M49%
Bacterial And General Sanitation$44.9M20%
Services$25.7M11%
Natural Toxins And Allergens$20.4M9%
Animal Care$8.9M4%
Genomics Services$6.3M3%
Biosecurity Products$4.6M2%
Life Sciences$1.4M1%

Related Comparisons